Breaking News Instant updates and real-time market news.

ACMR

ACM Research

$16.99

0.09 (0.53%)

, AEHR

Aehr Test Systems

$1.51

-0.02 (-1.31%)

08:18
07/10/19
07/10
08:18
07/10/19
08:18

Cowen, Stifel and Jefferies co-host a summit

11th Annual CEO Summit is being held in San Francisco on July 10.

ACMR

ACM Research

$16.99

0.09 (0.53%)

AEHR

Aehr Test Systems

$1.51

-0.02 (-1.31%)

ACLS

Axcelis

$14.85

-0.06 (-0.40%)

BRKS

Brooks Automation

$38.07

0.04 (0.11%)

CCMP

Cabot Microelectronics

$109.95

0.47 (0.43%)

COHU

Cohu

$14.56

-0.5 (-3.32%)

CYBE

Cyberoptics

$12.32

0.37 (3.10%)

FORM

FormFactor

$15.05

-0.6 (-3.83%)

ICHR

Ichor Holdings

$23.33

0.48 (2.10%)

INTT

inTEST

$4.67

-0.01 (-0.21%)

IVAC

Intevac

$4.96

-0.01 (-0.20%)

KLIC

Kulicke & Soffa

$21.38

-0.04 (-0.19%)

NANO

Nanometrics

$33.62

0.27 (0.81%)

PDFS

PDF Solutions

$13.19

0.06 (0.46%)

RTEC

Rudolph Technologies

$26.92

0.145 (0.54%)

VECO

Veeco

$11.50

-0.37 (-3.12%)

  • 18

    Jul

  • 24

    Jul

  • 31

    Jul

  • 01

    Aug

  • 05

    Aug

  • 07

    Aug

  • 08

    Aug

  • 12

    Sep

ACMR ACM Research
$16.99

0.09 (0.53%)

05/09/19
CHLM
05/09/19
NO CHANGE
Target $25
CHLM
Buy
ACM Research price target raised to $25 from $20 at Craig-Hallum
Craig-Hallum analyst Christian Schwab raised his price target for ACM Research to $25 from $20 following another better than expected quarter and a reiterated 2019 outlook. The analyst reiterates a Buy rating on the shares.
08/08/18
CHLM
08/08/18
NO CHANGE
Target $19.5
CHLM
Buy
ACM Research price target raised to $19.50 from $13 at Craig-Hallum
Craig-Hallum analyst Christian Schwab raised his price target for ACM Research to $19.50 from $13 following better results and guidance. The analyst reiterates a Buy rating on the shares.
AEHR Aehr Test Systems
$1.51

-0.02 (-1.31%)

ACLS Axcelis
$14.85

-0.06 (-0.40%)

02/08/19
BNCH
02/08/19
UPGRADE
Target $26.5
BNCH
Buy
Axcelis upgraded to Buy from Hold at Benchmark
Benchmark analyst Mark Miller upgraded Axcelis Technologies to Buy with a price target of $26.50. The analyst expects improvements for the company's memory sales as well as market share gains.
02/08/19
CHLM
02/08/19
DOWNGRADE
CHLM
Hold
Axcelis downgraded to Hold from Buy at Craig-Hallum
01/28/19
RILY
01/28/19
UPGRADE
Target $28
RILY
Buy
Axcelis upgraded to Buy from Neutral at B. Riley FBR
B. Riley FBR analyst Craig Ellis upgraded Axcelis Technologies to Buy and raised his price target for the shares to $28 from $18. The analyst says his analysis suggests a bottoming process in Semi Capital Equipment space can lead to a sustained rally in the stocks.
05/08/19
NORL
05/08/19
DOWNGRADE
NORL
Market Perform
Axcelis downgraded to Market Perform from Outperform at Northland
BRKS Brooks Automation
$38.07

0.04 (0.11%)

12/17/18
SBSH
12/17/18
NO CHANGE
SBSH
Buy
Citi adds 'positive catalyst watch' on Brooks Automation
Citi analyst Amanda Scarnati adds a "positive catalyst watch" on Brooks Automation after meeting with the company's management. The analyst says Brooks sounded the most positive of the group on her firm's bus tour, largely due to its "solid exposure to the life sciences market," Scarnati tells investors in a research note. The analyst expects Brooks Automation's relative share outperformance to continue in the first half of 2019 as the life sciences business continues to grow as a percentage of sales and the sale of the "low growth" semi cryo business closes. Scarnati has a Buy rating on the shares.
01/23/19
SBSH
01/23/19
NO CHANGE
SBSH
Citi moves Lam Research to top pick in Semiconductor Capital Equipment
Citi analyst Atif Malik lowered his 2019 wafer-fab equipment spend estimate to $40B, or down 22% year-over-year, versus his prior $44B to reflect weak Korea memory spending. The analyst also moved Lam Research (LRCX) to his number one pick and Applied Materials (AMAT) to number two. Previous top pick KLA-Tencor (KLAC) moves down to number three to reflect "prior stock performance into and out of memory downturns." Among smaller caps, the analyst moves Brooks Automation (BRKS) up to his top pick "due to the strength of the life sciences portfolio which should bring stability to top line relative to semi peers." Malik thinks Semiconductor Capital Equipment group returns look attractive "with the rationale to buy and hold long-term."
11/20/18
FBCO
11/20/18
NO CHANGE
Target $26
FBCO
Neutral
Brooks Automation price target lowered to $26 from $32 at Credit Suisse
Credit Suisse analyst John Pitzer lowered his price target for Brooks Automation to $26 from $32 after the company reported Q3 revenues in line, with EPS slightly above estimates, and guided Q4 below due to the divestiture of the Semiconductor Cryogenics business and the acquisition of the Genewiz business. The analyst reiterates a Neutral rating on the shares.
09/04/18
RILY
09/04/18
NO CHANGE
Target $50
RILY
Buy
Brooks Automation price target raised to $50 from $40 at B. Riley FBR
B. Riley FBR analyst Craig Ellis raised his price target for Brooks Automation to $50 citing the company's intensifying push into life sciences. The analyst reiterates a Buy rating on the shares.
CCMP Cabot Microelectronics
$109.95

0.47 (0.43%)

07/08/19
KING
07/08/19
INITIATION
Target $125
KING
Neutral
Cabot Microelectronics initiated with a Neutral at CL King
CL King initiated Cabot Microelectronics with a Neutral and $125 price target.
11/29/18
BUCK
11/29/18
INITIATION
Target $130
BUCK
Buy
Cabot Microelectronics initiated with a Buy at Buckingham
Buckingham analyst Dmitry Silversteyn initiated Cabot Microelectronics with a Buy and $130 price target. Silversteyn said the pullback in Cabot shares since the KMG Chemicals acquisition announcement in August has provided an attractive entry point and believes the addition of a rapidly growing and high margin DRA business will help drive profits and preserve its enviable margins.
07/08/19
07/08/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Best Buy (BBY) initiated with a Buy at Guggenheim. 2. Cabot Microelectronics (CCMP) was initiated with a Buy at Goldman Sachs and a Neutral at CL King. 3. Crowdstrike (CRWD) was initiated with an Outperform at Oppenheimer, Macquarie and JMP Securities, an Overweight at JPMorgan, Piper Jaffray and Barclays, a Buy at BofA/Merrill, Needham, Stifel, and Mizuho, a Neutral at Credit Suisse and Goldman Sachs, a Sector Perform at RBC Capital, and a Hold at SunTrust and Jefferies. 4. TriplePoint Venture (TPVG) initiated with a Buy at Nomura Instinet. 5. Fiverr (FVRR) was initiated with an Outperform at Oppenheimer and JMP Securities, a Buy at Needham, as well as a Neutral at JPMorgan, UBS and Citi. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/08/19
GSCO
07/08/19
INITIATION
Target $148
GSCO
Buy
Cabot Microelectronics initiated with a Buy at Goldman Sachs
Goldman Sachs started Cabot Microelectronics with a Buy rating and $148 price target. The firm sees the company as a key beneficiary of 3D NAND layer count growth.
COHU Cohu
$14.56

-0.5 (-3.32%)

03/13/19
DADA
03/13/19
NO CHANGE
Target $25
DADA
Buy
Cohu price target lowered to $25 from $28 at DA Davidson
DA Davidson analyst Thomas Diffely lowered his price target on Cohu to $25 after its lower than expected Q4 revenues and outlook for Q1 sales, saying the trends reflect a broad based industry softness in Mobility, Auto, and Industrial sectors. The analyst is keeping his Buy rating however, noting that the company's "relatively stable utilization rates and a few design wins" should drive a recovery in the second half of 2019. Diffely is maintaining his "bullish long term view" and contends that Cohu remains positioned to achieve $1B in revenue in the next few years.
05/07/19
STFL
05/07/19
UPGRADE
Target $22
STFL
Buy
Stifel upgrades Cohu to Buy on more confidence in fundamental bottom
Stifel analyst Brian Chin upgraded Cohu to Buy from Hold and raised his price target for the shares to $22 from $18.50. Following the company's Q1 results, the analyst has improved confidence that fundamentals have bottomed, a recovery is forming, and that Cohu will emerge in the next upcycle with an improved operating model. The "real new news" on the earnings call is the "dramatic pull-forward" of the company's cost restructuring, now anticipated to result in $40M annualized expense savings at the end of 2019, Chin tells investors in a research note. He believes current share levels offer an attractive entry point into Cohu.
05/07/19
STFL
05/07/19
UPGRADE
STFL
Buy
Cohu upgraded to Buy from Hold at Stifel
06/18/19
STFL
06/18/19
NO CHANGE
STFL
Buy
Semiconductor test equipment estimates lowered at Stifel
Stifel analyst Brian Chin said commentary directly from Huawei and its supply chain has further quantified the impact of recent trade restrictions and tariffs and with the "malaise in May now too acute to ignore" he has lowered his 2019 and 2020 revenue forecasts for semiconductor test equipment suppliers Teradyne (TER), Cohu (COHU) and FormFactor (FORM). However, he keeps Buy ratings on all three stocks as Chin thinks some of the near-term risk to estimates is already discounted and that a cyclical semi recovery "remains very much in play" for next year.
CYBE Cyberoptics
$12.32

0.37 (3.10%)

07/03/19
LSCM
07/03/19
NO CHANGE
Target $18
LSCM
Buy
Cyberoptics price target lowered to $18 from $25 at Lake Street
Lake Street analyst Jaeson Schmidt lowered his price target for Cyberoptics to $18 from $25 after the company yesterday reduced its Q2 revenue guidance. The analyst is "disappointed" that 2019 is now set up to be a transition year but he believes Cyberoptics' growth can return next year. As such, he thinks patient investors "will ultimately be rewarded" and maintains a Buy rating on the shares.
02/20/19
LSCM
02/20/19
NO CHANGE
Target $25
LSCM
Buy
Cyberoptics price target raised to $25 from $21 at Lake Street
Lake Street analyst Jaeson Schmidt raised his price target for Cyberoptics to $25 saying the company's "soft" Q1 guidance should not overshadow its continued new product traction. The analyst expects a second half of 2019 recovery and reiterates a Buy rating on Cyberoptics.
07/26/18
CHLM
07/26/18
NO CHANGE
Target $25
CHLM
Buy
Cyberoptics price target raised to $25 from $20 at Craig-Hallum
Craig-Hallum analyst Greg Palm raised his price target for Cyberoptics to $25 from $20, citing better Q2 results and overall bullish outlook. The analyst reiterates a Buy rating on the shares.
07/26/18
LSCM
07/26/18
NO CHANGE
Target $21
LSCM
Buy
Cyberoptics price target raised to $21 after earnings at Lake Street
Lake Street analyst Jaeson Schmidt noted that CyberOptics reported better than expected earnings and revenue and he thinks the opportunity for the company's 3D MRS-enabled products remains strong. Following the report, he reiterated his Buy rating and raised his price target to $21 from $19 on Cyberoptics shares.
FORM FormFactor
$15.05

-0.6 (-3.83%)

06/10/19
NEED
06/10/19
INITIATION
Target $19
NEED
Buy
FormFactor initiated with a Buy at Needham
Needham analyst N. Quinn Bolton initiated FormFactor with a Buy rating and $19 price target.
06/11/19
NEED
06/11/19
INITIATION
Target $19
NEED
Buy
FormFactor initiated with a Buy at Needham
Needham analyst N.Quinn Bolton initiated FormFactor with a Buy rating and a price target of $19. The analyst cites the company's position as an "indisputable leader in the growing probe card market" as well as its expanding market share reaching the size that is double that of its closest peers. Bolton believes that FormFactor stands to benefit from the "growth of both foundry/logic and memory", saying it is the only company whose products balance between these two end markets. The analyst also sees FormFactor gaining from the broader trends of higher wafer test intensity demand coming from advanced packaging, 5G, and automotive semiconductors sectors.
06/11/19
06/11/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. FormFactor (FORM) initiated with a Buy at Needham. 2. Victory Capital (VCTR) initiated with a Perform at Oppenheimer. 3. Agilent (A) initiated with an Overweight at Piper Jaffray. 4. Danaher (DHR) initiated with a Neutral at Piper Jaffray. 5. Amag Pharmaceuticals (AMAG) initiated with an Overweight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
ICHR Ichor Holdings
$23.33

0.48 (2.10%)

07/08/19
DADA
07/08/19
DOWNGRADE
DADA
Neutral
Ichor Holdings downgraded to Neutral from Buy at DA Davidson
05/16/19
RILY
05/16/19
INITIATION
Target $32
RILY
Buy
Ichor Holdings initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Craig Ellis started Ichor Holdings with a Buy rating and $32 price target.
05/16/19
05/16/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Jefferies starts 'underappreciated' Par Technology (PAR) with Buy rating. 2. Ichor Holdings (ICHR) initiated with a Buy at B. Riley FBR. 3. T2 Biosystems (TTOO) initiated with a Buy at Alliance Global Partners. 4. CV Sciences (CVSI) initiated with a Buy at Roth Capital. 5. Hillenbrand (HI) initiated with a Buy at Buckingham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/08/19
07/08/19
DOWNGRADE

Neutral
Semiconductor Capital Equipment group cut to Neutral at DA Davidson on valuation
As previously reported, DA Davidson analyst Thomas Diffely cut his ratings on Lam Research (LRCX), Kulicke and Soffa (KLIC), Ichor Holdings (ICHR), Applied Materials (AMAT), and Advanced Energy Services (AEIS) to Neutral from Buy as part of his broader research note downgrading the Semiconductor Capital Equipment group following its "significant" year-to-date appreciation. The analyst cites the delayed recovery in memory along with the "cycle uncertainty" in assigning more "conservative" valuation multiples to these stocks and believes that their risk-reward profiles look "fairly balanced" at current levels. Diffely also lowers his price target on Lam Research to $200 from $225, Kulicke and Soffa to $26 from $30, Ichor Holdings to $25 from $32, Applied Materials to $45 from $55, and Advanced Energy Services to $55 from $60.
INTT inTEST
$4.67

-0.01 (-0.21%)

12/28/18
DAWS
12/28/18
INITIATION
Target $10
DAWS
Buy
inTEST initiated with a Buy at Dawson James
Dawson James analyst Barry Sine initiated inTest with a Buy and $10 price target.
02/08/19
LSCM
02/08/19
INITIATION
Target $9
LSCM
Buy
inTEST initiated with a Buy at Lake Street
Lake Street analyst Jaeson Schmidt started inTEST with a Buy rating and $9 price target. The analyst believes investors do not fully appreciate how the company's 2017 acquisition of Ambrell increased its total addressable market, diversified revenue away from the more volatile semiconductor market, added scale, and positioned it for sustained growth. With a new annual addressable market of $620M, inTEST has a long runway for growth and should be able to achieve its long-term goal of $150M in revenue, Schmidt tells investors in a research note.
IVAC Intevac
$4.96

-0.01 (-0.20%)

07/31/18
BNCH
07/31/18
UPGRADE
BNCH
Buy
Intevac upgraded to Buy from Hold at Benchmark
07/31/18
07/31/18
UPGRADE
Target $6

Buy
Intevac upgraded to Buy on profitability expectations at Benchmark
As previously reported, Benchmark analyst Mark Miller upgraded Intevac to Buy from Hold on his view of the likelihood it can return to profitability in Q4 and 2019. He notes that Q2 earnings topped both the company's guidance and consensus, as did Q2 revenue. Miller set a $6 price target on Intevac shares.
01/03/19
BNCH
01/03/19
NO CHANGE
BNCH
Activision, Canopy Growth among Best Ideas for first half of 2019 at Benchmark
Benchmark analysts selected their Best Ideas for the first half of 2019, naming 16 stocks, including: Activision Blizzard (ATVI), BioTelemetry (BEAT), Biofrontera (BFRA), Ctrip (CTRP), Huazhu Group (HTHT), II-VI (IIVI), Intevac (IVAC), LHC Group (LHCG), Meredith (MDP), Marvell (MRVL), NeoGenomics (NEO), Pegasystems (PEGA), Silicon Labs (SLAB), Varonis (VRNS), Canopy Growth (CGC) and Waitr Holdings (WTRH).
12/20/18
12/20/18
NO CHANGE

Intevac awarded $6.9M production contract from U.S. Army
Intevac received a contract for $6.9M for the production of night vision cameras for the Apache Helicopter's Pilot Night Vision Sensor program for the U.S. Army. This contract vehicle enables the U.S. Army to procure additional units through May 2020 at pre-negotiated pricing.
KLIC Kulicke & Soffa
$21.38

-0.04 (-0.19%)

11/20/18
DADA
11/20/18
NO CHANGE
Target $32
DADA
Buy
Kulicke & Soffa price target lowered to $32 from $35 at DA Davidson
DA Davidson analyst Thomas Diffely lowered his price target on Kulicke & Soffa to $32 and also lowered his FY19 EPS view to $1.70 from $2.25, saying the weakness in China is accentuating its seasonal dip. The analyst cites the trade war uncertainty impacting current activity levels in China, along with the continued oversupply of NAND memory, and the recent buildout in capacity based on several strong quarters of shipments. The analyst also keeps his Buy rating on Kulicke & Soffa longer term, saying its fundamentals should "remain strong in the emerging data driven economy" and sees the "seemingly insatiable thirst for data and the resulting proliferation of chips and sensors" continue to drive the company's core, unit driven, wire bonding business for some time.
11/20/18
CHLM
11/20/18
INITIATION
Target $30
CHLM
Buy
Kulicke & Soffa initiated with a Buy at Craig-Hallum
Craig-Hallum analyst Christian Schwab started Kulicke & Soffa with a Buy rating and $30 price target. The analyst notes that management believes the current business softness will be short term in nature, and revenues are expected to stabilize at current levels and accelerate meaningfully in the 2H of FY19. Schwab believes the company's significant cash balance and meaningful multi-year earnings potential create an attractive risk/reward.
07/08/19
DADA
07/08/19
DOWNGRADE
DADA
Neutral
Kulicke & Soffa downgraded to Neutral from Buy at DA Davidson
NANO Nanometrics
$33.62

0.27 (0.81%)

06/19/19
RILY
06/19/19
INITIATION
Target $41
RILY
Buy
B. Riley FBR starts Nanometrics with Buy rating, $41 price target
B. Riley FBR analyst Craig Ellis last night initiated coverage of Nanometrics with a Buy rating and $41 price target. The analyst believes investors are overlooking the company's secular growth drivers and company-specific expansion potential because of lingering concerns over its China exposure. China accounts for only 10% of sales, yet Nanometrics shares are 30% below their 52-week high, Ellis tells investors in a research note. The analyst believes rising equipment intensity is a "powerful secular equipment spending driver" spanning all Nanometrics end markets.
06/18/19
RILY
06/18/19
INITIATION
Target $41
RILY
Buy
Nanometrics initiated with a Buy at B. Riley FBR
B. Riley FBR started Nanometrics with a Buy rating and $41 price target.
07/09/19
BNCH
07/09/19
NO CHANGE
BNCH
Alibaba, Take-Two among Benchmark's Best Ideas for second half
Benchmark's analyst team laid out their Best Ideas for the second half of 2019, naming Alibaba (BABA), Take-Two (TTWO), BioTelemetry (BEAT), Biofrontera (BFRA), Chembio Diagnostics (CEMI), Ctrip (CTRP), Green Thumb Industries (GTBIF), II-VI (IIVI), LivePerson (LPSN), Nanometrics (NANO), Nexstar (NXST), Pegasystems (PEGA), Tabula Rasa HealthCare (TRHC) and Waitr Holdings (WTRH) to their list.
06/25/19
BNCH
06/25/19
NO CHANGE
Target $39
BNCH
Buy
Nanometrics deal for Rudolph complementary and accretive, says Benchmark
Benchmark analyst Mark Miller said he views Nanometrics' (NANO) deal to merger with Rudolph Technologies (RTEC) favorably, calling the transaction "timely, complementary and accretive." Miller maintains a Buy rating and $39 price target on Nanometrics shares.
PDFS PDF Solutions
$13.19

0.06 (0.46%)

08/29/18
DADA
08/29/18
NO CHANGE
Target $13
DADA
Buy
PDF Solutions price target lowered to $13 from $18 at DA Davidson
DA Davidson analyst Thomas Diffely lowered his price target on PDF Solutions to $13 after yesterday's decision by Global Foundries, to put its 7nm program on hold and to drop its plans to pursue the next generation advanced nodes. The analyst states that while PDF Solutions' exposure to Global Foundries is declining from 40% to 30%, it is still its largest customer, and the announcement has a bearing on its already drifting core yield enhancement business. Diffely keeps his Buy rating on the shares however given the potential upside in the stock price after its 13% slide yesterday.
RTEC Rudolph Technologies
$26.92

0.145 (0.54%)

10/04/18
RILY
10/04/18
NO CHANGE
Target $30
RILY
Buy
Rudolph Technologies price target lowered to $30 from $36 at B. Riley FBR
B. Riley FBR analyst Craig Ellis lowered his price target for Rudolph Technologies (RTEC) to $30 after the company reduced its outlook for Q3. The lowered outlook reflects two separate customer pushouts, which the analyst believes are Global Foundries and Micron Technology (MU). The analyst keeps a Buy rating on Rudolph Technologies.
09/10/18
SIDC
09/10/18
UPGRADE
SIDC
Buy
Rudolph Technologies upgraded to Buy from Neutral at Sidoti
10/04/18
STFL
10/04/18
NO CHANGE
Target $30
STFL
Buy
Rudolph Technologies price target lowered to $30 from $35 at Stifel
Stifel analyst Patrick Ho lowered his price target on Rudolph Technologies shares to $30 from $35 after the company's negative preannouncement, which he views as somewhat disappointing given Rudolph's more diversified product portfolio and market exposure relative to other comparable companies. However, the front-end weakness has been evident and is not a complete surprise, Ho added. He maintains a Buy rating on Rudolph shares as he remains positive on the long-term fundamental story.
VECO Veeco
$11.50

-0.37 (-3.12%)

05/07/19
BNCH
05/07/19
UPGRADE
BNCH
Buy
Veeco upgraded to Buy from Hold at Benchmark
05/07/19
BNCH
05/07/19
UPGRADE
Target $15
BNCH
Buy
Veeco upgraded to Buy on expectations for improved margins at Benchmark
As previously reported, Benchmark analyst Mark Miller upgraded Veeco Instruments to Buy from Hold as he believes that rising orders and backlog along with an improved mix and lower costs should push non-GAAP margins up to the 40% range by the fourth quarter. He set a $15 price target on Veeco.
05/16/19
BNCH
05/16/19
NO CHANGE
BNCH
II-VI, Lumentum may be hurt by Huawei news, says Benchmark
After the U.S. Commerce Department added Huawei Technologies and 70 affiliates to its "Entity List," which bans the Chinese company from acquiring components and technology from U.S. companies without government approval, Benchmark analyst Mark Miller noted that prior restrictions negatively impacted II-VI (IIVI), which counts Huawei among its customers. He also believes Lumentum (LITE) may be unfavorably impacted as Huawei represents about 15% of its revenue. Huawei has contributed about 13% of Micron's (MU) sales in the last two quarters and shares of Western Digital (WDC) often trade in a similar manner to Micron, added Miller. Others that he sees potentially being negatively impacted by the Huawei news include IPG Photonics (IPGP), Coherent (COHR), nLight (LASR) and Veeco (VECO).
03/06/19
STFL
03/06/19
DOWNGRADE
Target $12
STFL
Hold
Veeco downgraded to Hold from Buy at Stifel
Stifel analyst Patrick Ho downgraded Veeco to Hold from Buy, calling the change "essentially a valuation move" after the stock reached his unchanged $12 price target. He does not believe there are any "new" catalysts that would lead him to increase estimates or raise his target price in the near-term, Ho tells investors.

TODAY'S FREE FLY STORIES

FITB

Fifth Third

$30.24

0.365 (1.22%)

, CSCO

Cisco

$43.83

0.29 (0.67%)

18:37
12/06/19
12/06
18:37
12/06/19
18:37
Hot Stocks
Fifth Third issues statement on temporary network outage »

Fifth Third Bank (FITB)…

FITB

Fifth Third

$30.24

0.365 (1.22%)

CSCO

Cisco

$43.83

0.29 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

  • 12

    Dec

  • 08

    Jan

  • 12

    Feb

STML

Stemline

$10.33

0.5 (5.09%)

, PFE

Pfizer

$38.29

0.26 (0.68%)

18:33
12/06/19
12/06
18:33
12/06/19
18:33
Hot Stocks
Stemline names Robert Francomano as Chief Commercial Officer »

Most recently, Francomano…

STML

Stemline

$10.33

0.5 (5.09%)

PFE

Pfizer

$38.29

0.26 (0.68%)

GSK

GlaxoSmithKline

$45.51

0.29 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Dec

  • 11

    Dec

GOL

Gol Linhas

$17.39

1.07 (6.56%)

18:31
12/06/19
12/06
18:31
12/06/19
18:31
Hot Stocks
Gol Linhas announces preliminary traffic figures for November »

GOL's domestic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAVB

Navidea

$0.97

0.07 (7.78%)

18:25
12/06/19
12/06
18:25
12/06/19
18:25
Syndicate
Navidea announces $1.9M private placement »

Navidea announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFC

Ellington Financial

$18.22

0.09 (0.50%)

18:23
12/06/19
12/06
18:23
12/06/19
18:23
Hot Stocks
Ellington Financial reports estimated book value per share $18.51 on November 30 »

This estimate includes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOOT

Boot Barn

$41.93

0.81 (1.97%)

18:22
12/06/19
12/06
18:22
12/06/19
18:22
Hot Stocks
Boot Barn CEO: More than 80% of our business is in the store »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERIC

Ericsson

$9.24

0.1 (1.09%)

18:18
12/06/19
12/06
18:18
12/06/19
18:18
Hot Stocks
Ericsson to pay over $1B to settle FCPA case »

Ericsson has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

GLD

SPDR Gold Shares

$137.59

-1.42 (-1.02%)

17:55
12/06/19
12/06
17:55
12/06/19
17:55
Hot Stocks
SPDR Gold Shares holdings fall to 886.23MT from 888.57MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PICO

PICO Holdings

$10.81

0.31 (2.95%)

17:45
12/06/19
12/06
17:45
12/06/19
17:45
Hot Stocks
PICO Holdings sells long-term storage credits for $8.7M in Arizona »

PICO Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QHC

Quorum Health

$0.95

0.0522 (5.81%)

17:31
12/06/19
12/06
17:31
12/06/19
17:31
Hot Stocks
Quorum Health receives NYSE continued listing standard notice »

Quorum Health Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPRT

Support.com

$1.94

0.01 (0.52%)

17:30
12/06/19
12/06
17:30
12/06/19
17:30
Hot Stocks
Breaking Hot Stocks news story on Support.com »

Support.com trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXRX

Baudax Bio

$6.69

0.34 (5.35%)

17:29
12/06/19
12/06
17:29
12/06/19
17:29
Syndicate
Breaking Syndicate news story on Baudax Bio »

Baudax Bio files $125M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

LMT

Lockheed Martin

$387.10

1.175 (0.30%)

17:25
12/06/19
12/06
17:25
12/06/19
17:25
Hot Stocks
Lockheed Martin awarded $153.39M Navy contract modification »

Lockheed Martin was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENV

Envestnet

$71.72

1.27 (1.80%)

17:23
12/06/19
12/06
17:23
12/06/19
17:23
Syndicate
Breaking Syndicate news story on Envestnet »

Envestnet files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOC

Northrop Grumman

$344.79

0.4 (0.12%)

17:20
12/06/19
12/06
17:20
12/06/19
17:20
Hot Stocks
Northrop Grumman awarded $189M Navy contract modification »

Northrop Grumman was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPRT

Support.com

$1.94

0.01 (0.52%)

17:03
12/06/19
12/06
17:03
12/06/19
17:03
Hot Stocks
Support.com announces special distribution of $1.00 per share »

The record date for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPRT

Support.com

$1.94

0.01 (0.52%)

17:01
12/06/19
12/06
17:01
12/06/19
17:01
Hot Stocks
Breaking Hot Stocks news story on Support.com »

Support.com trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RZLT

Rezolute

$0.00

(0.00%)

17:00
12/06/19
12/06
17:00
12/06/19
17:00
Syndicate
Breaking Syndicate news story on Rezolute »

Rezolute files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,750.79

10.2 (0.59%)

16:58
12/06/19
12/06
16:58
12/06/19
16:58
Periodicals
U.S. mulls putting Amazon foreign sites on 'Notorious Markets' list, WSJ says »

The Trump administration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGTA

Magenta Therapeutics

$13.29

0.3 (2.31%)

16:55
12/06/19
12/06
16:55
12/06/19
16:55
Conference/Events
Magenta Therapeutics to hold an investor and analyst event »

Investor and Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

IMH

IMPAC Mortgage

$5.63

-0.01 (-0.18%)

16:54
12/06/19
12/06
16:54
12/06/19
16:54
Syndicate
Breaking Syndicate news story on IMPAC Mortgage »

IMPAC Mortgage files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALEC

Alector

$19.74

0.33 (1.70%)

16:32
12/06/19
12/06
16:32
12/06/19
16:32
Hot Stocks
Alector reports Phase 1 safety, biomaker data on AL002 »

Alector reported safety…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATAX

America First Multifamily Investors

$7.58

0.125 (1.68%)

16:31
12/06/19
12/06
16:31
12/06/19
16:31
Hot Stocks
America First Multifamily Investors CFO Craig Allen to retire »

On December 2,Craig Allen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
12/06/19
12/06
16:30
12/06/19
16:30
Options
Preliminary option volume of 20.4M today »

Preliminary option volume…

PNM

PNM Resources

$48.77

-0.06 (-0.12%)

16:29
12/06/19
12/06
16:29
12/06/19
16:29
Hot Stocks
PNM Resources raises quarterly dividend 6% to 30.75c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.